AJMC January 12, 2025
Tiago Biachi, MD, PhD, highlighted the transformative role of personalized medicine in gastrointestinal (GI) cancer treatment through advances in next-generation sequencing and circulating tumor DNA, while emphasizing the importance of lifestyle factors in prevention and recurrence.
Personalized medicine is having a transformative impact in treating gastrointestinal (GI) cancers, with advances in next-generation sequencing enabling more targeted therapies and enhancing both treatment and patient management, explained Tiago Biachi, MD, PhD, a colorectal oncologist and GI cancer specialist at Moffitt Cancer Center.
He also emphasized the importance of lifestyle factors, such as obesity and lack of exercise, in GI cancer prevention and recurrence and underscored the critical role of interdisciplinary teams in managing GI cancers.
This transcript has been lightly edited for...
Today's Sponsors
Today's Sponsor